Gooreind Pharma SRL
4.4 FTEThe score of Gooreind Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -18 % Total assets -14 % Headcount (avg FTE) +33 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Gooreind Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 59,344 € | ||||
| Equity | 390,026 € | ||||
| Cash | 100,334 € | ||||
| EBITDA | 145,282 € | ||||
| Total assets | 791,241 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 04 Aug 2026
- Year ended 31 Dec 2024filed on 15 Jul 2025
- Year ended 31 Dec 2023filed on 23 Jul 2024
- Year ended 31 Dec 2022filed on 26 Jun 2023
- Year ended 31 Dec 2021filed on 07 Jul 2022
Gooreind Pharma's financial analysis
- Solvency49.3%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Gooreind Pharma
Gooreind Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0870.403.170
- VAT number
- BE0870403170
- Peppol
- Registered · 0208:0870403170 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 06 Dec 2004
- Registered office
- 2990 Wuustwezel
- Size
- Micro · 4.4 FTE
- Latest accounts
- 2025 · filed on 04 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Gooreind Pharma (SRL) has been based in Wuustwezel since 2004, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 59,344 € and equity of 390,026 €; its revenue is not published. With 4.4 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 49.3%, above the median of its sector (44.2%).
Companies similar to Gooreind Pharma
Companies in the same business, of comparable size and area, outside its group.
- Cobra Apotheek Centrum Retail sale of pharmaceutical products Mol · balance sheet 791,276 €
- Apotheek Declerck Retail sale of pharmaceutical products Kortrijk · balance sheet 790,903 €
- Paal Farma Retail sale of pharmaceutical products Beringen · balance sheet 790,795 €
- Pharmacie TASSIN Retail sale of pharmaceutical products Beyne-Heusay · balance sheet 791,772 €
- Dr. Apr. D. Kieffer Retail sale of pharmaceutical products Hasselt · balance sheet 790,139 €
- Hpharma Retail sale of pharmaceutical products Fleurus · balance sheet 789,401 €
- WD-Farma Retail sale of pharmaceutical products Antwerp · balance sheet 787,913 €
- Sanimed Retail sale of pharmaceutical products Oudenburg · balance sheet 786,238 €
Frequently asked questions about Gooreind Pharma
What is the revenue of Gooreind Pharma?
Gooreind Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Gooreind Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0870403170 for Gooreind Pharma, if the company is VAT-registered. Its company number (CBE) is 0870.403.170.
Where is the registered office of Gooreind Pharma?
According to the CBE register, the registered office of Gooreind Pharma is in 2990 Wuustwezel.
What is the equity of Gooreind Pharma?
At the close of the 2025 financial year, the equity of Gooreind Pharma amounts to 390,026 €, a solvency of 49.3% of total assets.
How many people work at Gooreind Pharma?
4.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Gooreind Pharma?
The register lists 4 active mandates at Gooreind Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Gooreind Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →